Annual Total Expenses
$8.00 B
+$733.00 M+10.08%
31 December 2023
Summary:
Biogen annual total expenses is currently $8.00 billion, with the most recent change of +$733.00 million (+10.08%) on 31 December 2023. During the last 3 years, it has fallen by -$993.80 million (-11.04%). BIIB annual total expenses is now -11.04% below its all-time high of $9.00 billion, reached on 31 December 2020.BIIB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$1.97 B
+$206.40 M+11.71%
30 September 2024
Summary:
Biogen quarterly total expenses is currently $1.97 billion, with the most recent change of +$206.40 million (+11.71%) on 30 September 2024. Over the past year, it has dropped by -$326.10 million (-14.21%). BIIB quarterly total expenses is now -41.01% below its all-time high of $3.34 billion, reached on 31 December 2020.BIIB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIIB Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | -14.2% |
| 3 y3 years | -11.0% | -1.6% |
| 5 y5 years | +7.4% | +5.4% |
BIIB Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -11.0% | +10.1% | -14.2% | +17.1% |
| 5 y | 5 years | -11.0% | +10.1% | -41.0% | +19.8% |
| alltime | all time | -11.0% | >+9999.0% | -41.0% | +546.4% |
Biogen Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.97 B(+11.7%) |
| June 2024 | - | $1.76 B(+2.5%) |
| Mar 2024 | - | $1.72 B(-10.8%) |
| Dec 2023 | $8.00 B(+10.1%) | $1.93 B(-16.0%) |
| Sept 2023 | - | $2.30 B(+25.1%) |
| June 2023 | - | $1.83 B(-5.7%) |
| Mar 2023 | - | $1.95 B(-3.5%) |
| Dec 2022 | $7.27 B(-11.0%) | $2.02 B(+19.7%) |
| Sept 2022 | - | $1.68 B(+0.1%) |
| June 2022 | - | $1.68 B(-11.0%) |
| Mar 2022 | - | $1.89 B(-12.0%) |
| Dec 2021 | $8.17 B(-9.2%) | $2.15 B(+7.4%) |
| Sept 2021 | - | $2.00 B(-11.9%) |
| June 2021 | - | $2.27 B(+29.5%) |
| Mar 2021 | - | $1.75 B(-47.5%) |
| Dec 2020 | $9.00 B(+22.6%) | $3.34 B(+44.0%) |
| Sept 2020 | - | $2.32 B(+36.6%) |
| June 2020 | - | $1.70 B(+3.2%) |
| Mar 2020 | - | $1.64 B(-14.9%) |
| Dec 2019 | $7.34 B(-1.5%) | $1.93 B(+3.3%) |
| Sept 2019 | - | $1.87 B(+11.1%) |
| June 2019 | - | $1.68 B(-9.5%) |
| Mar 2019 | - | $1.86 B(-7.1%) |
| Dec 2018 | $7.45 B(+10.5%) | $2.00 B(+11.4%) |
| Sept 2018 | - | $1.80 B(-13.0%) |
| June 2018 | - | $2.06 B(+29.8%) |
| Mar 2018 | - | $1.59 B(-13.5%) |
| Dec 2017 | $6.74 B(+16.4%) | $1.84 B(+31.9%) |
| Sept 2017 | - | $1.39 B(-19.7%) |
| June 2017 | - | $1.74 B(-2.2%) |
| Mar 2017 | - | $1.78 B(+16.7%) |
| Dec 2016 | $5.79 B(+0.8%) | $1.52 B(+0.6%) |
| Sept 2016 | - | $1.51 B(+6.3%) |
| June 2016 | - | $1.42 B(+6.5%) |
| Mar 2016 | - | $1.34 B(-14.0%) |
| Dec 2015 | $5.75 B(-0.6%) | $1.55 B(+10.5%) |
| Sept 2015 | - | $1.41 B(+3.3%) |
| June 2015 | - | $1.36 B(-4.8%) |
| Mar 2015 | - | $1.43 B(-3.3%) |
| Dec 2014 | $5.79 B(+30.3%) | $1.48 B(+4.6%) |
| Sept 2014 | - | $1.41 B(-1.4%) |
| June 2014 | - | $1.43 B(-2.1%) |
| Mar 2014 | - | $1.46 B(+11.4%) |
| Dec 2013 | $4.44 B(+20.8%) | $1.31 B(+14.2%) |
| Sept 2013 | - | $1.15 B(+7.4%) |
| June 2013 | - | $1.07 B(+18.1%) |
| Mar 2013 | - | $907.35 M(-7.8%) |
| Dec 2012 | $3.68 B(+12.5%) | $983.88 M(+12.9%) |
| Sept 2012 | - | $871.76 M(-3.3%) |
| June 2012 | - | $901.23 M(-2.2%) |
| Mar 2012 | - | $921.10 M(+3.9%) |
| Dec 2011 | $3.27 B(+3.9%) | $886.81 M(+8.5%) |
| Sept 2011 | - | $817.14 M(+2.7%) |
| June 2011 | - | $795.63 M(+3.3%) |
| Mar 2011 | - | $770.47 M(+41.7%) |
| Dec 2010 | $3.15 B(+2.1%) | $543.76 M(-44.6%) |
| Sept 2010 | - | $981.65 M(+20.2%) |
| June 2010 | - | $816.82 M(+1.4%) |
| Mar 2010 | - | $805.17 M(+8.3%) |
| Dec 2009 | $3.08 B(+7.5%) | $743.68 M(+1.0%) |
| Sept 2009 | - | $736.34 M(-15.4%) |
| June 2009 | - | $870.38 M(+19.0%) |
| Mar 2009 | - | $731.53 M(-2.9%) |
| Dec 2008 | $2.87 B(+24.3%) | $753.20 M(+0.8%) |
| Sept 2008 | - | $747.11 M(+7.2%) |
| June 2008 | - | $696.65 M(+3.8%) |
| Mar 2008 | - | $671.18 M(+12.8%) |
| Dec 2007 | $2.31 B(+19.6%) | $595.23 M(-4.6%) |
| Sept 2007 | - | $624.22 M(+10.1%) |
| June 2007 | - | $566.84 M(+8.7%) |
| Mar 2007 | - | $521.38 M(+3.2%) |
| Dec 2006 | $1.93 B | $505.15 M(+0.8%) |
| Sept 2006 | - | $501.05 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2006 | - | $486.53 M(+11.0%) |
| Mar 2006 | - | $438.48 M(-16.4%) |
| Dec 2005 | $2.07 B(-4.6%) | $524.35 M(-5.4%) |
| Sept 2005 | - | $554.00 M(+14.5%) |
| June 2005 | - | $483.77 M(-4.4%) |
| Mar 2005 | - | $506.24 M(-4.5%) |
| Dec 2004 | $2.17 B(+40.0%) | $529.86 M(+12.2%) |
| Sept 2004 | - | $472.44 M(-12.5%) |
| June 2004 | - | $540.23 M(-13.6%) |
| Mar 2004 | - | $625.61 M(-53.6%) |
| Dec 2003 | $1.55 B(+713.7%) | $1.35 B(+1906.9%) |
| Sept 2003 | - | $67.13 M(-16.5%) |
| June 2003 | - | $80.42 M(+48.6%) |
| Mar 2003 | - | $54.10 M(-112.3%) |
| Dec 2002 | $190.35 M(-72.1%) | -$441.20 M(-301.2%) |
| Sept 2002 | - | $219.25 M(+1.0%) |
| June 2002 | - | $217.12 M(+11.2%) |
| Mar 2002 | - | $195.18 M(+4.7%) |
| Dec 2001 | $682.11 M(+14.2%) | $186.45 M(+6.2%) |
| Sept 2001 | - | $175.61 M(+3.6%) |
| June 2001 | - | $169.51 M(+12.6%) |
| Mar 2001 | - | $150.48 M(-0.9%) |
| Dec 2000 | $597.31 M(+24.9%) | $151.81 M(-10.3%) |
| Sept 2000 | - | $169.27 M(+18.0%) |
| June 2000 | - | $143.42 M(+8.0%) |
| Mar 2000 | - | $132.81 M(+2.4%) |
| Dec 1999 | $478.18 M(+30.3%) | $129.68 M(+4.6%) |
| Sept 1999 | - | $124.00 M(+7.9%) |
| June 1999 | - | $114.90 M(+4.6%) |
| Mar 1999 | - | $109.80 M(+6.1%) |
| Dec 1998 | $366.95 M(+28.7%) | $103.45 M(+6.6%) |
| Sept 1998 | - | $97.00 M(+10.5%) |
| June 1998 | - | $87.80 M(+12.7%) |
| Mar 1998 | - | $77.90 M(+0.4%) |
| Dec 1997 | $285.08 M(+20.7%) | $77.58 M(+7.6%) |
| Sept 1997 | - | $72.10 M(+12.3%) |
| June 1997 | - | $64.20 M(-9.4%) |
| Mar 1997 | - | $70.90 M(-11.4%) |
| Dec 1996 | $236.26 M(+63.8%) | $80.06 M(+33.0%) |
| Sept 1996 | - | $60.20 M(+12.1%) |
| June 1996 | - | $53.70 M(+26.7%) |
| Mar 1996 | - | $42.40 M(+8.3%) |
| Dec 1995 | $144.25 M(-8.8%) | $39.15 M(+7.0%) |
| Sept 1995 | - | $36.60 M(+1.1%) |
| June 1995 | - | $36.20 M(+10.0%) |
| Mar 1995 | - | $32.90 M(+0.5%) |
| Dec 1994 | $158.25 M(+38.0%) | $32.75 M(-43.5%) |
| Sept 1994 | - | $58.00 M(+61.6%) |
| June 1994 | - | $35.90 M(+12.9%) |
| Mar 1994 | - | $31.80 M(-23.6%) |
| Dec 1993 | $114.70 M(+20.6%) | $41.60 M(+61.2%) |
| Sept 1993 | - | $25.80 M(+0.8%) |
| June 1993 | - | $25.60 M(+10.8%) |
| Mar 1993 | - | $23.10 M(-16.6%) |
| Dec 1992 | $95.10 M(+51.7%) | $27.70 M(-4.8%) |
| Sept 1992 | - | $29.10 M(+40.6%) |
| June 1992 | - | $20.70 M(+15.0%) |
| Mar 1992 | - | $18.00 M(+6.5%) |
| Dec 1991 | $62.70 M(+27.2%) | $16.90 M(+6.3%) |
| Sept 1991 | - | $15.90 M(+6.0%) |
| June 1991 | - | $15.00 M(+1.4%) |
| Mar 1991 | - | $14.80 M(+19.4%) |
| Dec 1990 | $49.30 M(+31.5%) | $12.40 M(-3.1%) |
| Sept 1990 | - | $12.80 M(0.0%) |
| June 1990 | - | $12.80 M(+10.3%) |
| Mar 1990 | - | $11.60 M(+7.4%) |
| Dec 1989 | $37.50 M(+15.4%) | $10.80 M(+10.2%) |
| Sept 1989 | - | $9.80 M |
| Dec 1988 | $32.50 M(-0.9%) | - |
| Dec 1987 | $32.80 M(-7.6%) | - |
| Dec 1986 | $35.50 M(-26.0%) | - |
| Dec 1985 | $48.00 M(+11.4%) | - |
| Dec 1984 | $43.10 M | - |
FAQ
- What is Biogen annual total expenses?
- What is the all time high annual total expenses for Biogen?
- What is Biogen annual total expenses year-on-year change?
- What is Biogen quarterly total expenses?
- What is the all time high quarterly total expenses for Biogen?
- What is Biogen quarterly total expenses year-on-year change?
What is Biogen annual total expenses?
The current annual total expenses of BIIB is $8.00 B
What is the all time high annual total expenses for Biogen?
Biogen all-time high annual total expenses is $9.00 B
What is Biogen annual total expenses year-on-year change?
Over the past year, BIIB annual total expenses has changed by +$733.00 M (+10.08%)
What is Biogen quarterly total expenses?
The current quarterly total expenses of BIIB is $1.97 B
What is the all time high quarterly total expenses for Biogen?
Biogen all-time high quarterly total expenses is $3.34 B
What is Biogen quarterly total expenses year-on-year change?
Over the past year, BIIB quarterly total expenses has changed by -$326.10 M (-14.21%)